Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: Results from a privately insured patient population

Prostate Cancer and Prostatic Diseases

Volumn 18, Issue 1, 2015, Pages 13-17

  Kim, S P ^a,b,c   Gross, C P ^b,d   Smaldone, M C ^e   Han, L C ^f   Van Houten, H ^f   Lotan, Y ^g   Svatek, R S ^h   Thompson, R H ⁱ   Karnes, R J ⁱ   Trinh, Q D ^j   Kutikov, A ^e   Shah, N D ^f  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b YALE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁱ DEPARTMENT OF UROLOGY   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL EVALUATION; DISEASE ASSOCIATION; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; POPULATION RESEARCH; PRIVATE HEALTH INSURANCE; PROSTATE CANCER; PROSTATECTOMY; REIMBURSEMENT; SURGICAL APPROACH; ECONOMICS; PATHOLOGY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

ADULT; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; LENGTH OF STAY; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 84922641025     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2014.38     Document Type: Article

References (32)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Anderson JE, Chang DC, Parsons JK, Talamini MA. The first national examination of outcomes and trends in robotic surgery in the United States. J Am Coll Surg 2012; 215: 107-114.
3. Wright JD, Ananth CV, Lewin SN, Burke WM, Lu YS, Neugut AI et al. Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA 2013; 309: 689-698.
4. Hu JC, Gu X, Lipsitz SR, Barry MJ, D'Amico AV, Weinberg AC et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 2009; 302: 1557-1564.
5. Nguyen PL, Gu X, Lipsitz SR, Choueiri TK, Choi WW, Lei Y et al. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol 2011; 29: 1517-1524.
6. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148: 435-448.
7. Kowalczyk KJ, Levy JM, Caplan CF, Lipsitz SR, Yu HY, Gu X et al. Temporal National Trends of Minimally Invasive and Retropubic Radical Prostatectomy Outcomes from 2003 to 2007: Results from the 100% Medicare Sample. Eur IUrol 2011; 61: 803-809.
8. Hu JC, Wang Q, Pashos CL, Lipsitz SR, Keating NL. Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol 2008; 26: 2278-2284.
9. Ficarra V, Cavalleri S, Novara G, Aragona M, Artibani W. Evidence from robot-assisted laparoscopic radical prostatectomy: a systematic review. Eur Urol 2007; 51: 45-55; discussion 56.
10. Ficarra V, Novara G, Artibani W, Cestari A, Galfano A, Graefen M et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 2009; 55: 1037-1063.
11. Jacobs BL, Zhang Y, Schroeck FR, Skolarus TA, Wei JT, Montie JE et al. Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA 2013; 309: 2587-2595.
12. Mirkin JN, Lowrance WT, Feifer AH, Mulhall JP, Eastham JE, Elkin EB. Direct-to-consumer Internet promotion of robotic prostatectomy exhibits varying quality of information. Health Aff (Millwood) 2012; 31: 760-769.
13. Kim SP, Shah ND, Karnes RJ, Weight CJ, Shippee ND, Han LC et al. Hospitalization costs for radical prostatectomy attributable to robotic surgery. Eur Urol 2012; 64: 11-16.
14. Trinh QD, Sammon J, Sun M, Ravi P, Ghani KR, Bianchi M et al. Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the Nationwide Inpatient Sample. Eur Urol 2012; 61: 679-685.
15. Makarov DV, Yu JB, Desai RA, Penson DF, Gross CP. The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care 2011; 49: 333-339.
16. Neuner JM, See WA, Pezzin LE, Tarima S, Nattinger AB. The association of robotic surgical technology and hospital prostatectomy volumes: increasing market share through the adoption of technology. Cancer 2012; 118: 371-377.
17. Gandaglia G, Sammon JD, Chang SL, Choueiri TK, Hu JC, Karakiewicz PI et al. Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol 2014; 32: 1419-1426.
18. Gandaglia G, Abdollah F, Hu J, Kim S, Briganti A, Sammon JD et al. Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional cancer treatments. J Endourol/Endourol Soc 2014; 28: 784-791.
19. IMS Institute for Healthcare Informatics. Available at: http://www.imshealth.com/portal/site/imshealth/menuitem.d583644423e6edf2f786f7861ad8c22a/?vgnextoid=598de5fda6370410VgnVCM10000076192ca2RCRD&vgnextfmt=default. (last accessed 1 January 2014).
20. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.
21. Consumer price indexes for major expenditure classes 1965-2009. Available at: http://www.gpo.gov/fdsys/pkg/ERP-2010/pdf/ERP-2010-table60.pdf. (last accessed 1 December 2012).
22. Manning WG, Willard G, Mullahy J. Estimating log models: to transform or not transform? J Health Econ 2001; 20: 461-494.
23. Effron B. Bootstrap methods: another look at the jackknife. Biometrics 1979; 7: 1-26.
24. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011; 103: 117-128.
25. Bolenz C, Freedland SJ, Hollenbeck BK, Lotan Y, Lowrance WT, Nelson JB et al. Costs of radical prostatectomy for prostate cancer: a systematic review. Eur Urol 2012; 65: 316-324.
26. Trinh QD, Sammon J, Sun M, Ravi P, Ghani KR, Bianchi M et al. Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. Eur Urol 2012; 61: 679-685.
27. Begg CB, Riedel ER, Bach PB, Kattan MW, Schrag D, Warren JL et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002; 346: 1138-1144.
28. Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 2003; 21: 401-405.
29. Lotan Y, Bolenz C, Gupta A, Hotze T, Ho R, Cadeddu JA et al. The effect of the approach to radical prostatectomy on the profitability of hospitals and surgeons. BJU Int 2010; 105: 1531-1535.
30. Barbash GI, Glied SA. New technology and health care costs - the case of robot-assisted surgery. N Engl J Med 2010; 363: 701-704.
31. Kim SP, Boorjian SA, Shah ND, Weight CJ, Tilburt JC, Han LC et al. Disparities in access to hospitals with robotic surgery for patients with prostate cancer undergoing radical prostatectomy. J Urol 2013; 189: 514-520.
32. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009; 101: 1325-1329.